Novira Therapeutics Lands $10,995,221 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c05e1fa9-7681-484d-b02b-83447c1f3c95&Preview=1 -
Date
8/23/2012 -
Company Name
Novira Therapeutics -
Mailing Address
Undisclosed Los Angeles, CA 90041 -
Company Description
Novira is an antiviral drug discovery company launched in 2009 that is focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV, two global diseases in need of better therapies. The company is led by seasoned pharmaceutical industry executives with proven records of success in drug discovery. The company has identified and is further optimizing a promising pipeline of drugs that disrupt virus capsid assembly of HIV and HBV using an efficient and innovative model of biomedical research. -
Website
http://www.noviratherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$10,995,221 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
